Dstock Im trying to understand this research you provided.ClinicalTrials.gov ID NCT02852655 Are you saying that Merck wanted to reactivate with additional rGBM patients to better understand Pembro's MOA ? Can we conclude that DCVax L could/did enhance Pembros MOA based on the additional 25?